It’s official. Today, December 18, 2025, President Donald Trump signed an Executive Order directing the Attorney General to “take all necessary steps to complete the rulemaking process related to ...
Carriers are still required to randomly select 50% of their drivers for random drug tests, and 10% for random alcohol tests.
The random drug and alcohol testing rate for FMCSA-regulated workers hasn't been changed since 2020. Plus, FMCSA proposes ...
The legal landscape for workplace drug testing is likely to see some significant changes in 2026. This article summarizes the ...
President Donald Trump on Thursday signed an executive order expediting the reclassification of marijuana as a less dangerous substance, giving the Food and Drug Administration (FDA) the green light ...
Analysis from AltLine shows the exact opposite of the strong support Overdrive readers had for DOT's non-domiciled CDL ...
President Donald Trump confirmed this week that his administration is “looking very strongly” at rescheduling marijuana from Schedule I to Schedule III under the Controlled Substances Act. Cannabis ...
The FDA has published new guidance aimed at reducing or stopping toxicity studies of monoclonal antibody-based drugs in non-human primates (NHPs), in the latest stage of an ongoing effort to reduce ...
President Donald Trump signed a Dec. 18 executive order directing agencies to move cannabis from Schedule I to Schedule III, restarting a stalled federal rulemaking process. The shift could boost ...
This year the Trump administration overhauled the trucking industry by rolling out aggressive deregulation, canceling speed limiter mandates, and tightening driver English-language standards.
New York has become the latest target in the U.S. Department of Transportation’s crackdown on illegally issued non-domiciled commercial driver’s licenses. At a Dec. 12 press conference, DOT Secretary ...
Reports of the drug xylazine being detected in overdoses across the U.S. have been making news lately and present a new challenge in addressing our ongoing overdose crisis. Xylazine, sometimes ...